Tag: Cancer: Skin

Two-year overall survival 72 percent for those starting with N/I, 52 percent for those starting with dabrafenib/trametinib

While most report sunscreen use, substantial number also report having had sunburns

Darker skin types underrepresented among publicly available skin image datasets used to inform skin cancer diagnosis

Compared with placebo, pembrolizumab prolonged regression-free survival in resected high-risk stage IIB and IIC melanoma

Prior therapy linked to lower objective response rate to adoptive cell transfer with tumor-infiltrating lymphocytes compared with no prior therapy

Authors recommend that dermatologists perform a total-body skin examination even when a patient is referred for a suspicious lesion

Beta-HPV detected in skin swabs may predict cuSCC risk, but no link seen for serologic evidence of past beta-HPV infection

Overall response rate of 69.7 percent seen with topical HDAC inhibitor; complete resolution observed for 54.8 percent of tumors on pathologic exam

Odds for melanoma detection highest for presence of white structures, pseudopods, irregular pigmentation, blue-white veil, and peppering

AAD survey revealed that 49 percent of respondents were more worried about avoiding sunburn than preventing skin cancer